Greetings, mooers!
In this special edition, we're excited to bring you the motivating story of @WolfRun, who achieved a remarkable milestone by growing five stocks in his portfolio by tenfold. Don't miss our interactive giveaway at the end of this post!
*Disclaimer: All views expressed in the Mooers' Stories are the independent opinions of WolfRun, which do not reflect the opinions, views, or positions of Moomoo F...

$Interactive Strength (TRNR.US)$
🤣

$Interactive Strength (TRNR.US)$
Interactive Strength Inc. (Nasdaq:TRNR) Secures Exclusive Distribution and Initial Order for CLMBR in United Kingdom
Tuesday, 4th March at 7:00 am
The United Kingdom is the world's 3rd largest fitness market
New UK Partner, Cranlea Human Performance, has sold CLMBRs to leading UK health clubs, including David Lloyd Clubs
Cranlea's 50-Year History and Leading In-Market Relationships are expected to significantly strengthen CLMBR's position in the UK
AUSTIN, TX ...

$Icecure Medical (ICCM.US)$
IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China
Monday, 27th January at 8:30 am
Seeks to expand regulatory approval in China where IceSense3 has already been approved
CAESAREA, Israel, Jan. 27, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, t...

$Icecure Medical (ICCM.US)$ Icecure Files for Regulatory Approval of Prosense® Cryoablation System in China

$Icecure Medical (ICCM.US)$
IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization Decision
Tuesday, 4th February at 8:30 am
Two independent studies of ProSense® cryoablation in breast cancer were presented, one of which won the Highest Scoring Abstract Award in its category
Hands-on ProSense® training featured during the S...

$Icecure Medical (ICCM.US)$ IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in Israel

Application covering a wide range of indications is in line with trends in de-escalation of surgery and growth in minimally invasive cryoablation procedures, pointing to strong potential for increasing demand

CAESAREA, Israel, February 24, 2025 – IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure”, “IceCure Medical” or the “Company”), developer of minimally-...